follow-up - risky stocknot sure what you expect as industry coverage is almost non-existent in the sense of brokerage coverage. Northland capital (focus on small and mid size firms) life science is not a thriving industry and therefore no money in it - why cover
Taylor Colliison is down under - where there has been little to no uptake on their products and company as a whole
one year chart has been going only 1 way - down fast
so why invest - people who are in now really don't hold any hope
- company's last financials indicated increase in admin and research expenses and a decrease in overall revenues - high burn rate which will eat cash on hand at a rate of 1M per month
- company padded the retirement plan and issued 1,050,00 in stock options to directors, officers and employees
-resignation of CTO
sure they may have potential but as far as risk goes - everything points down.....